Nal Pharmaceuticals

Nal Pharmaceuticals is a clinical-stage pharmaceutical company specializing in the development of innovative drug delivery systems to improve the efficacy and safety of existing medications. The company focuses on proprietary technologies such as bio-adhesive transdermal patches and oral thin films to address unmet needs in central nervous system disorders, pain management, and other therapeutic areas. By reformulating proven active pharmaceutical ingredients, Nal aims to provide patients with more convenient and effective treatment options. Their pipeline includes advanced candidates for Alzheimer's disease, Parkinson's disease, and chronic pain, primarily utilizing the 505(b)(2) regulatory pathway.